Today on DrugResearcher.com   Semen fibrils ferry HIV into cells Shire snaps up Alba's gastrointestinal drug for $325m Curiox' mini-bioassay tech to aid cheaper drug development Japan says Tamiflu/psychiatric link unclear New cell line to tackle drug resistant cancer

Related Industry News   Pronova and FMC to develop seaweed-derived capsules Double whammy as Merck kids' vaccines recalled and suspended Pharmaceutical manufacturing: news in brief Biomarker detection gets 'sticky'

Breaking News on Drug Discovery
Daily  Monday 17 December 2007		Forward to a colleague

	Access Full Stories Semen fibrils ferry HIV into cells Tiny protein fibres in semen have been found to enhance the ability of HIV to infect cells by up to 100,000 fold and could provide drug developers with a potent new target to tackle the virus... Read Shire snaps up Alba's gastrointestinal drug for $325m US biopharma firm Alba Therapeutics has received a boost to its coffers after Shire agreed to pay up to $325m (€226m) to help bring its lead gastrointestinal drug candidate to market... Read Curiox' mini-bioassay tech to aid cheaper drug development Curiox Biosystems has developed a miniaturisation platform that enables cheaper and more efficient bioassays to be conducted, potentially slashing the costs of life science and drug discovery research... Read Japan says Tamiflu/psychiatric link unclear Any link between the antiviral Tamiflu and neuropsychiatric problems is inconclusive, according to the Japanese Government... Read New cell line to tackle drug resistant cancer The creation of a new 'super cell' that can stand firm against one of the newest types of cancer therapy could shed new light on how to treat patients if they become resistant to these drugs... Read
	All News Headlines for: December | November | October
	Related Industry News Pronova and FMC to develop seaweed-derived capsules Pronova BioPharma and FMC Corporation have signed a license and development agreement to develop products using an alginate-based capsule technology... Read Double whammy as Merck kids' vaccines recalled and suspended Merck has been hit with a contamination threat prompting the recall of a million of its childhood Hib vaccines across the US, right alongside the Canadian suspension of its MMR vaccine... Read Pharmaceutical manufacturing: news in brief In-PharmaTechnologist.com brings you a selection of recent headlines from around the pharmaceutical manufacturing industry... Read Biomarker detection gets 'sticky' US researchers have developed a fast and inexpensive protein biomarker detection device that could simplify disease diagnosis and aid in following disease progression in drug trials... Read Weekly Comment Paediatric drugs and testing highlighted The importance of paediatric drug formulations and clinical trials in children was highlighted at this month's American Association of Pharmaceutical Scientists (AAPS) conference in San Diego. Read Previous Headlines Biogen Idec shares nosedive after withdrawing 'for sale' sign Like countless pets after every Christmas, it seems that nobody wanted Biogen Idec after all; the firm has announced it will remain independent after it 'did not receive any definitive offers to purchase the company'... Read Merck confirms diabetes retreat Merck Serono intends to forge ahead with severing its investment in diabetes and either sell or partner out its existing research and development (R&D) activities in this field, which it no longer feels able... Read BioWa and Lonza agreement for potent antibodies BioWa and Lonza are joining forces to develop a new technology platform to produce more potent antibodies with enhanced cell-killing powers... Read Mini synchrotron to ease structural analysis? Researchers have developed a miniature synchrotron that could enable researchers to conduct protein crystallography experiments in their own university and 'revolutionise the way science is done'... Read Roche targets Ventana's board to force takeover The latest twist in Roche's long-running bid to acquire diagnostics expert Ventana has seen the pharma giant announce it intends to elect directors to Ventana's board at its next AGM (annual general meeting)... Read Technical / White Papers, Case studies, Web casts Manufacturing Variations in Polysorbate Batches - Technical / White Paper Product Information - brochures, Web centers DAICEL chiral chromatography products - Company Profile Separation of polar compounds - Application Notes Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com